Caplacizumab Completed Phase 1 Trials for Healthy Volunteers Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT03172208Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.